National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$59.95
add to cart

Rights & Permissions

topleft topright

Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us (2001)
Commission on Behavioral and Social Sciences and Education (CBASSE)

Citation Manager

. "2 Determinants and Consequences of Drug Use." Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us. Washington, DC: The National Academies Press, 2001.

Please select a format:

BibTeX EndNote RefMan


Page
41
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Informing America’s Policy on Illegal Drugs: What We Don’t Know Keeps Hurting Us

TABLE 2.1 Classification of Abusive and Additive Drugs

Class

Description

Caffeine

Produces wakefulness, mild central nervous system (CNS) and cardiovascular stimulation, Mild tolerance, dependence following chronic use.

Alcohol

Produces dose-dependent relaxation, disinhibition, mild euphoria, inebriation, intoxication, CNS depression, liver damage. Significant tolerance and dependence-withdrawal following chronic use; intense craving, alcoholism.

Nicotine

Produces mild CNS and cardiovascular stimulation. Tolerance and dependence-withdrawal following chronic use; intense craving; nicotine addiction.

Depressants (sedatives, hypnotics, anxiolytics): barbiturates, methadqualone, diazepam, and other benzodiazepines

Produce dose-dependent relaxation, disinhibition, mild euphoria, inebriation, intoxication, CNS depression. Significant tolerance and dependence withdrawal following chronic use; craving; addiction.

Cannabinoids (marijuana, hashish: tetrahydrocannabinol (THC)

Produce dose-dependent relaxation, disinhibition; alterations of mood, emotion and behavior; inebriation, intoxication. Mild tolerance.

Opiates (opioids) and related analgesics: heroin, codeine, morphine, synthetic opioids.

Produce dose-dependent analgesia, euphoria, disinhibition, anesthesia, CNS depression. Significant tolerance and dependence-withdrawal following chronic use; intense craving; opioid addiction.

Stimulant: cocaine, amphetamine, methamphetamine, methylphenidate

Produce dose-dependent mild-strong CNS stimulation, behavioral hyperactivity, adverse cardiovascular effects, euphoria. Tolerance and dependence withdrawal following chronic use; intense craving; addiction.

Hallucinogens: lysergic acid diethylamide (LSD), mescaline, psilocybin, dimethyltryptamine (DMT), dimethoxymethylamphetamine (DOM), MDA, MDMA (“ecstasy”), phensyclidine (PCP; “angel dust”) ketamine

Symptoms vary depending on which drug: visual distortions, hallucinations, mood changes, arousal, euphoria, anxiety, agitation, emotional withdrawal, thought disturbances, aggressive behavior, panic, catatonia. Mild tolerance with chronic use; little or no withdrawal.

Inhalants: solvents, aerosols, acetone, benzene, nitrous oxide, amyl nitrate

Produce dose-dependent relaxation, mild euphoria, dizziness, disinhibition, inebriation, intoxication, anesthesia, CNS depression, liver damage, cardiovascular depression.

 

Source: Institute of Medicine (1997: Table 1.1).

Page
41